Latest Queensland News

Monash IVF Group reported steady FY25 financial results with revenue and EBITDA growth, while managing clinical incidents and a CEO transition. The company outlines cautious FY26 guidance amid industry headwinds.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million in FY25 but saw an 8.1% decline in underlying net profit after tax to $27.4 million, impacted by market softness and operational incidents. The company outlines cautious FY26 guidance amid ongoing sector headwinds.

Pacgold Limited reports significant gold intersections from its 2025 drilling program at the Alice River Gold Project, confirming extensions to its Mineral Resource Estimate and advancing high-priority targets including the compelling White Lion prospect.

Larvotto Resources has raised $10 million through a Share Purchase Plan, bolstering its financial position as it advances the Hillgrove Project toward production slated for Q2 2026.

Boom Logistics reported solid FY25 results with a 41% jump in operating profit, driven by strong contract wins in resources and renewables and a strategic asset regeneration program.

Vysarn Limited delivered a robust FY2025 performance, driven by significant acquisitions and expanding operations across Australia’s water infrastructure sector. The company’s strategic moves position it well for sustained growth amid evolving market demands.

PWR Holdings Limited posted a 6.7% revenue decline and a 60.6% drop in net profit for FY2025, impacted by contract completions and factory relocation. Despite short-term setbacks, the company is investing heavily in new facilities, aerospace growth, and sustainability initiatives.

Vonex Limited shareholders are set to vote on a court-approved scheme of arrangement for Maxo Telecommunications to acquire the remaining 30.6% stake, offering a significant premium. The scheme promises a timely cash exit amid sector uncertainties.

Healius Limited reported a 5.7% rise in FY25 revenue driven by pathology growth, while underlying EBIT fell 27% impacted by cyclone disruptions and restructuring. The company advances its pathology strategy and cost savings post-Lumus divestment.

Healius reported a 5.7% rise in FY25 revenue with underlying EBIT meeting consensus, buoyed by strong pathology growth and a significant profit from the Lumus Imaging sale. Despite challenges at Agilex Biolabs and a major goodwill impairment, the company targets improved margins by 2027.

Peet Limited delivered a robust FY25 performance with a 60% jump in net operating profit and a strong sales pipeline, while initiating a strategic review to capitalize on favorable market conditions.

Reef Casino Trust faces a new takeover challenge as Morris Group submits a conditional $191.7 million cash offer, competing with the board-backed Iris proposal. The trust’s Independent Board Committee urges unitholders to hold off while assessing the competing bids.